SANTRO

The Sino-American Network for Therapeutic Radiology and Oncology

Saturday Morning conference can be remotely accessed via: https://cwru.zoom.us/j/414808287 Please RSVP to RSVP@SANTRO.ORG for your presence of Oct 20th Scientific program by Oct 16th

Newsletter Special Edition

A letter from SANTRO 10-Year Celebration Chairs August 28, 2018 Dear Colleagues and Friends,

N BEHALF OF THE Sino-American Network for Therapeutic Radiology and Oncology (SANTRO, www.santro.org), we are honored to invite you to join us for the 10-year SANTRO celebrating symposiums and ceremonies. The theme of this celebrating series is “Together bridg-

ing the future” aiming to deliver better care of cancer patients without boundaries. We will have scientific sessions around the annual meeting of American Society of Radiation Oncology (ASTRO) at San Antonio, the United States, with a focus on the role of radiotherapy in the era of Immune ther-apy and during the annual meeting of Chinese Society of Radiation Oncology (CSTRO) at Hanzhou China, on the Latest Trends in Radiation Oncology, and Taizhou China focusing on win-win collaborations between physicians and physicists and the conduct of meaningful clinical trials. SANTRO is A bridge between the Chinese and American radiation oncology communities. SANTRO’s missions are to foster communications between medical professionals from the United States and China to deliver high-qual-ity radiation therapy to cancer patients and to sponsor educational events and research collaborations. The series of SANTRO 10-year celebrating gath-erings will provide not only a unique opportunity for radiation oncology pro-fessionals both in China and around the world, to share knowledge, but also create a forum to establish more win–win collaborations in clinical re-search/clinical trials, clinical patient care and training of the young genera-tions of radiation oncology professionals across the Pacific Ocean.

O

SANTRO 10-Year Birthday Celebration Programs

At a Glance

SANTRO at ASTRO

October 20-21, 2018

San Antonio, USA

October 20, 2018

7:00 AM-1:00 PM

Hildalgo Ballroom,

Westin Riverwalk Hotel

Visions from the leaders, keynote

speeches, young investigator presen-

tations & learning the global visions

of NRG oncology/RTOG and NCI/NIH

October 21, 2018

1:00 PM-3:00 PM

Room 007C/D,

Henry B. Gonazalez

Convention Center

Big data in radiation oncology

6:00 PM-10:00 PM

Hildalgo Ballroom,

Westin Riverwalk Hotel

Cocktail, award ceremony and

dinner reception, everyone is invited

SANTRO at CSTRO

November 9, 2018

Hangzhou, China

2:00 PM – 6:00 PM

SANTRO Symposium

The Latest Trends in

Radiation Oncology

6:00 PM – 9:00 PM

SANTRO Reception, by invitation only

SANTRO at Taizhou Symposium

December 8-10, 2018

Taizhou, China

Precision medicine in radiation on-

cology, win-win opportunities in col-

laborations between physicians and

physicists, and in conduct of

meaningful clinical trials

Together Bridging the Future

SANTRO Newsletter October 2018 Issue 2

2 | P a g e

We will have leaders, young and established investigators from CSTRO, ASTRO, ESTRO, NRG Oncology and NIH to share their vision of win-win collaborations and will have scientific presentations from top award winning abstracts from Junior Investigators. We look forward to welcoming you to join the celebrating activities. Sincerely yours,

Feng-Ming (Spring) Kong, MD, PhD, FACR, FASTRO SANTRO President of 2008-2010, Chair of Founding Board Directors, 2018 Board Director SANTRO 10-Year Celebration Chair

Luhua Wang, MD President of CSTRO, Vice President of Chinese National Cancer Hospital SANTRO 10-Year Celebration Co-Chair

Jinming Yu, MD, PhD President of Shandong Cancer Hospital, Academician of Chinese College of Engineer SANTRO 10-Year Celebration Co-Chair Zhongxing Liao, MD SANTRO Founding Board Director, 2018 Board Director SANTRO 10-Year Celebration Co-Chair

Allen Li, PhD, FAAPM SANTRO President of 2018-2020, 2018 Board Director SANTRO 10-Year Celebration Co-Chair

Organizing Committee Members Feng-Ming (Spring) Kong (Chair) Allen Li (Co-chair), Brian Wang, Chi Lin, Dian Wang, FangFang Yin, Ning Jeff Yue, Jinming Yu (Co-Chair), Ken Zhen, Joe Chang, Ming Chen (Secretary), Lei Dong, Ligang Xing, Luhua Wang (Co-Chair), Ping Xia, Ying Hitchcock, Ying Li (Secretary), Shiyu Song (Secretary), Yuenan Wang, Zhongxing Liao

Scientific Committee Members Shiyu Song (Chair), Lei Dong (co-Chair), Allen Li, Brian Wang, Chi Lin, Dian Wang, Feng-Ming (Spring) Kong, Ning Jeff Yue, Ying Hitchcock, Meng Welliver, Ken Zhen, Ping Xia, Zhongxing Liao

Award Committee Members Feng-Ming (Spring) Kong (co-Chair), Ning Jeff Yue (co-Chair), Allen Li, Brian Wang, Chi Lin, Dian Wang, Shiyu Song

SANTRO Newsletter October 2018 Issue 2

3 | P a g e

SANTRO 10-Year Celebration Event Details

SANTRO at ASTRO 2018

Saturday, October 20, 2018, San Antonio, USA

7 AM-1:00 PM

Hildalgo Ballroom, Westin riverside Hotel You can join the meeting remotely from PC, Mac, Linux, iOS or Android: https://cwru.zoom.us/j/414808287 7:00 AM - 8:00 AM Breakfast and Registrations Ying Hitchcock MD and Jianyue Jin PhD 8:00 AM - 10:00 AM TOGETHER BRIDGING THE FUTURE Session Co-Chairs: Feng-Ming (Spring) Kong, MD, PhD, FACR, FAAWR, FAS-TRO, Case Western Reserve University Allen Li, PhD, FAAPM, Medical College of Wisconsin Jinming Yu, MD, PhD, Shandong Cancer Hospital /Insti-tute Shandong University 8:00 AM - 8:10 AM Practice Changing Initiatives from American Society of Radiation Oncology (ASTRO) Theodore DeWeese, MD, PhD, Johns Hopkins University President Elect of ASTRO 8:10 AM - 8:20 AM The Advances of Radiation Oncology in China Luhua Wang, MD, Chinese National Cancer Institute Cancer Hospital President of Chinese Society of Radiation Oncology (CSTRO) 8:20 AM - 8:30 AM The Evolving Role of Sino-American Network of Thera-peutic Radiology and Oncology (SANTRO) in Modern Era of Radiation Oncology? Allen Li, PhD, FAAPM, Medical College of Wisconsin President of SANTRO

8:30 AM - 8:40 AM Exciting Projects in Radiation Oncology from the Euro-pean Society of Radiation Oncology (ESTRO) Ben J. Slotman, MD, VU University Medical Center President Elect of the European Society of Radiation Oncology 8:40 AM - 8:50 AM What is Going On in South East Asian Radiation Oncol-ogy Group (SEAROG)? Nonette Cupino, MD, Lung Cancer Center, St. Luke's Medical Center, Quezon City, Philippines 2016 President of Philippines Society of Radiation On-cology, on Behalf of the President of SEAROG 8:50 AM - 9:00 AM Global Vision of NCI/NIH: The Potential Funding Oppor-tunities for Radiation Oncologists Jeff Buchsbaum, MD, Program Director of Radiation Oncology, National Can-cer Institute (NCI)/National Institute of Health (NIH) 9:00 AM - 9:10 AM NCI TICA Project: What We Can Do Together for Better Cancer Care? Janet Early, MD, Associate Director for Cancer Imaging, NCI/NIH 9:10 AM - 9:25 AM Scientific Keynote 1: Clinical Trials in Radiation Im-munomodulation in China Jinming Yu, MD, Shandong Cancer Hospital/Institute Shandong University Former President of CSTRO, Academician of Chinese College of Engineer

SANTRO Newsletter October 2018 Issue 2

4 | P a g e

9:25 AM - 9:40 AM Scientific Keynote 2: Role of Radiation Therapy and Immunotherapy in Solid Tumor Yang-Xin Fu, MD, PhD, Mary Neil and Ralph B Rogers’ Professor, Departments of Pathology, immunology and Radiation Oncology, UT Southwestern 9:40 AM - 10:00 AM Panel Discussion: Where is the Win-win Opportunity? Expert Panelists: Ralph Weichselbaum, MD, University of Chicago Dian Wang, MD, PhD, Rush University Ken Zhen, MD, FACR, FASTRO, University of Nebraska Joe Chang, MD, FASTRO, MD Anderson Cancer Center Jeff Ning, PhD, FAAPM, Robert Wood Johnson Univer-sity Jianyue jin, PhD, Case Western Reserve University Ligang Xing, MD, Shandong Cancer Center Zhen Zhang, MD, PhD, Shanghai Cancer Hospital, Fu-dan University 10:00 AM - 10:10 AM Coffee Break 10:10 AM - 11:20 AM WHAT DOES THE FUTURE HOLD FOR RADIATION OOCOLOGISTS? Session Co-Chairs: Shiyu Song, MD, PhD, Virginia Commonwealth Univer-sity Health System Lei Dong, PhD, University of Pennsylvania Dennis Deng, PhD, Sun Yat- Sen University Cancer Hos-pital 10:10 AM - 11:40 AM Award Winning Scientific Presentations 10:10 AM: ABSTRACT_ID 17 A Randomized Phase II Trial of Neoadjuvant Chemo-therapy Compared with Chemoradiotherapy in Locally Advanced Gastric Adenocarcinoma. Xin Wang1, Jing Jin1, Dong-Bing Zhao2, Yihebali Chi3, Lin Yang3, Li-Ming Jiang4, Jun Jiang4, Li-Zhou Dou5, Yuan Tang1, Ning Li1, Wen-Yang Liu1, Yan-Tao Tian2, Hong Zhao2, Xiao-Feng Bai2, Xu Che2, Chun-Guang Guo2,

Ning-Ning Lu1, Hua Ren1, Hui Fang1, Shu-Lian Wang1, Yong-Wen Song1, Yue-Ping Liu1, Ye-Xiong Li1 1Department of Radiation Oncology, 2Department of Pancrea-gastric Surgery, 3Department of Medical On-cology, 4Department of Radiology, 5Department of En-doscopyNational, Cancer Center/National Clinical Re-search Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medi-cal College, Beijing, China 10:18 AM: ABSTRACT_ID 27 Integrated Treatment Response Prediction Model Combining Radiomic Features and Dosimetric Parame-ters for Esophageal Cancer Patients Underwent Chemoradiation Using Machine Learning. Xiance Jin, Xiaomin Zheng, Congying Xi Wenzhou Medical University 1st Affiliated Hospital, Wenzhou, China 10:26 AM: ABSTRACT_ID 44 Pretreatment PET/CT Imaging of Angiogenesis Based on 18F-RGD Tracer Uptake may Predict Antiangiogenic Response. Li Li1,2, Shuanghu Yuan*2,3, Li Ma2, Dongping Shang2, Zhiguo Liu2, Qingxi Yu2, Suzhen Wang2, Qiang Zhang4, Jinming Yu2. 1School of Medicine and Life Sciences, University of Ji-nan-Shandong Academy of Medical Sciences, Jinan, Shandong, China, 2 Shandong Cancer Hospital and In-stitute-Shandong Cancer Hospital Affiliated to Shan-dong University, Jinan, Shandong, China, 3 Shandong Academy of Medical Sciences, Jinan, Shandong, China, 4 Zibo Forth People's Hospital, Zibo, Shandong, China 11:32 AM: ABSTRACT_ID 91 Final Results of a Phase 3 Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esopha-geal Carcinoma (ESO-Shanghai 1). Yun Chen1, Jinjun Ye2, Zhengfei Zhu1, Weixin Zhao1, Ling Li1, Min Fan1, Chaoyang Wu3, Huarong Tang3, Gang Xu3, Qin-Lin4, Jiancheng Li5, Yi Xia6, Yunhai Li6, Jialiang Zhou7, Kuaile Zhao1 1Fudan University Shanghai Cancer Center, Shanghai, China; 2Jiangsu Cancer Hospital, Nanjing, China; 3Zhen-jiang First People’s Hospital, Zhenjiang, China; 4The First Affiliated Hospital of Xiamen University, Xiamen, China; 5Fujian Provincial Cancer Hospital, Fuzhou,

SANTRO Newsletter October 2018 Issue 2

5 | P a g e

China; 6 Fudan University Shanghai Cancer Center Min-hang Branch, Shanghai, China; 7Affiliated Hospital of Jiangnan University, Wuxi, China 10:40 AM: ABSTRACT_ID 26 Evaluating the Tumor Heterogeneity in Lung Cancer by Constructing Tumor Heterogeneity Index (THI) from Magnetic Resonance Imaging. Qiwen Li, MD, PhD1,2,3, Nanjie Gong, PhD4,5, Bo Qiu, MD, PhD1,2,3, Haoqiang He, MD1,2,6, Jihong Wang, PhD7, Yongquan Ye, PhD4,5, Jinyu Guo, MS1,2,3, Steven H Lin, MD, PhD8, Peiqiang Cai, MD1,2,6, Qun Chen, PhD4, Hongdi Li, PhD5, Chuanmiao Xie, MD1,2,6, Hui Liu, MD, PhD1,2,3

1State Key Laboratory of Oncology in South China, Guangzhou, People’s Republic of China; 2Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China; 3Guangdong Association Study of Thoracic On-cology, Guangzhou, People’s Republic of China; 4Re-search Collaboration, United Imaging Healthcare, Shanghai, China; 5UIH America, Houston, Taxes, USA; 6Department of Radiology, Sun Yat-sen University Can-cer Center, Guangzhou, Guangdong, People’s Republic of China; 7Department of Radiology, MD Anderson Cancer Center, Houston, Taxes, USA; 8Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Taxes, USA 10:48 AM: ABSTRACT_ID 36 Cyclooxygenase-2 Genetic Variants are Predictive of

Patient Benefit：Biomarker Analyses from a Random-ized Phase II Trial Evaluating Concurrent Chemoradio-therapy with or without Celecoxib in Unresectable Stage III Non-small Cell Lung Cancer. Nan Bi, Jun Liang, Zongmei Zhou, Dongfu Chen, Zhixue Fu, Xu Yang, Zhouguang Hui, QinFu Feng, Zefen Xiao, Jima Lv, Xiaozhen Wang, Tao Zhang, Xin Wang, Lei Deng, Wenqing Wang, Jingbo Wang, Juntao Ran, Luhua Wang Department of radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,17 Pan-jiayuannan Street, Chaoyang District, Beijing, P. R. China

10:56 AM: ABSTRACT_ID 10B Phase III Randomized Trial of Comparing Chemoradio-therapy vs. Radiotherapy Alone in Lymph Node Nega-tive Patients With Early-Stage Cervical Cancer Follow-ing Radical Hysterectomy. Congying Xie, Ph.D, Xiance Jin, Ph.D, Lili Li, MS, Department of Radiation and Medical Oncology, the 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 11:04 AM: ABSTRACT_ID 49 A proposal of N classification based on quantitative metastatic lymph node regions in nasopharyngeal car-cinoma. Xin Zhou, Xiaomin Ou, Chunying Shen, Chaosu Hu Fudan University Shanghai Cancer Center, Shanghai 11:12 AM: Questions and Answers 11:20 AM CLINICAL TRIAL AND INDUSTRIAL COLLABORATIONS Session Co-Chairs: Zhongxing Liao, MD, FASTRO, MD Anderson Cancer Center Ying Xiao, PhD, FAAPM, University of Pennsylvania Clinical Trial Keynote: Global Vision of NRG Oncology: Winning Opportunities in Clinical Trials Wally Curran, MD, FACR, FASCO, Winship Cancer Institute, Emory University Group Chair of NRG Oncology 11:40 AM Varian Medical Inc.: What is New from Varian? Kevin Lo, DHSc Sr. Director Marketing and Software Sales Asia Pacific Corey Zankowski President, Oncology Software Solutions, Varian Medical System

SANTRO Newsletter October 2018 Issue 2

6 | P a g e

11:55 AM Eleckta Inc.: What is New from Elekta? Jianbin Liu, VP & Marketing Director, Elekta China 12:10 PM Expert panel discussions: Clinical Trial and Industrial Collaborations FangFang Yin, PhD, FAAPM, FASTRO, Duke University Medial Center Min Yao, MD, PhD, FASTRO, Case Western Reserve Uni-versity Ping Xia, PhD, FAAPM, Cleveland Clinic Simon Lo, MD, FACR, FASTRO, University of Washing-ton, Seattle Xing Lei, PhD, FAAPM, Stanford University Ying Li, MD, San Antonia University Medical Center Ying Hitchcock, MD, Utah University, Huntsman Cancer Center 12:30 PM Lunch Poster Discussions Co-Chairs: Feng-Ming (Spring) Kong, MD, PhD, FACR, FAAWR, FAS-TRO, Case Western Reserve University Brian Wang, PhD, FAAPM, University of Louisville Ying Li, MD, San Antonia University Medical Center Posterwalk and Discussions with the Expert Professors (Questions and Answers) All SANTRO Board Members Onsite POSTER PRESENTATIONS ABSTRACT_ID 93: Lung Irradiation Contributes to Thrombocytopenia in Lung Cancer Patients Shanshan Tang, Department of Radiation Oncology, Shandong Cancer Hospital and Institute ABSTRACT_ID 38b: Palliative Radiation Therapy for Metastatic Primary Sig-net Ring Cell Carcinoma of the Lung: A SEER Analysis J. Wen1, X. Xu1, J. Chen1, D. Liu1, L. Xie1, J. Zhang2, and M. Fan1; 1Fudan University Shanghai Cancer Center, Shanghai, China, 2Department of Radiation Oncology, Fudan Uni-versity Shanghai Cancer Center, Shanghai, China

ABSTRACT_ID 93: Lung Irradiation Contributes to Thrombocytopenia in Lung Cancer Patients Shanshan Tang, Wenju Liu, Li Li, Yiqiang Qi, Aijun Jiang, Qingxi Yu, Suzhen Wang, Haimin Lin, Ning Liu, Shuanghu Yuan* Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Jinan, China ABSTRACT_ID 2: Can CT-derived Radiomics Features be Correlated with Intrinsic Pathological Tumor Characteristics in Invasive Adenocarcinomas of the Lung? Zijian Zhang1, Pei Yang2,3, Tingting Chen1, Dennis Mackin3, Hesham Elhalawani3, Lin Wu2, Hui Wang2, RongRong Zhou1, Zhan Liang1, Meilin Jiang2, Wenying Peng2, Yingrui Shi2, Abdallah Mohamed3, Laurence Court3, Clifton Fuller3, Hekun Jin2, Jianping Li4, Yaping Wang1 1Xiangya Hospital, Central South University, Changsha, China; 2Hunan Cancer Hospital, Changsha,China; 3The University of Texas MD Anderson Cancer Center, Hou-ston, TX, US; 4The First Affiliated Hospital of University of South China, Hengyang, China ABSTRACT_ID 66: Application of Radiomics Signature Captured from Pre-treatment CT to Predict Brain Metastases in Stage III/IV Non-small Cell Lung Cancer Patients with ALK Mutation X. Xu, M. Fan, J. Chen, L. Huang, J. Wang, J. Wen ,D. Liu, J. Zhang; Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, China ABSTRACT_ID 5: Post-radiotherapy PET/CT for Predicting Treatment Outcomes in Head and Neck Cancer after Postopera-tive Radiation; Y. Li1, M.J. Awan2, T. Chang2, P. Lavertu2, C. Zender2, R. Rezaee2, N. Fowler2, J. Wasman2, P. Faulhaber2, M. Machtay2, and M. Yao2*; 1West China Hospital of Si-chuan University, Chengdu, China2 University Hospital, Cleveland Medical Center, Cleveland, OH, USA

SANTRO Newsletter October 2018 Issue 2

7 | P a g e

ABSTRACT_ID 8: Continuous Intravenous Recombinant Human En-dostatin Pump Combined with Stereotactic Body Radi-ation Therapy for Elderly Patients with Early Stage Non-Small Cell Lung Cancer Ping Peng, Qianxia Li, Jinlin Wang, Xin Yang, Peng Zhang, Lu Zhang, Shu Xia, Qian Chu, Yuan Chen, Li Zhang Department of Oncology, Tongji Hospital, Tongji Med-ical College, Huazhong University of Science and Tech-nology, Wuhan, China ABSTRACT_ID 39: Radiomics Analysis of Skeletal Muscle Predicts Grade 3 or Higher Acute Gastrointestinal Toxicity in Rectal Can-cer Patients Receiving Neoadjuvant Chemoradiother-apy Fan Xia1, Wang Yang1, Ye Yuan1, Jiazhou Wang1, Wei-gang Hu1, Ji Zhu1, Zhen ZHANG1 1Department of Radiation Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, China ABSTRACT_ID 52: The Deregulation of lnc XR_429159.1 could Promote BM in Patients with SCLC Ji Li1, Wang Jing2, Hui Zhu1 1Shandong Cancer Hospital affiliated to Shandong Uni-versity, Jinan/China, 2Shandong Cancer Hospital, Jinan, China ABSTRACT_ID 9: Study of the Relationship between Peripheral Blood Cell Parameters and Prognosis of Intensity Modulated Radiotherapy for Esophageal Squamous Cell Carci-noma; Shuchai Zhu, Shuguang Li, Li Li, Ke Yan, Yan Zhao, Chun-yang Song, Youmei Li. Department of Radiation Oncology, The Fourth Hospi-tal of Hebei Medical University, China ABSTRACT_ID 43: Slight Advantages of Nimotuzumab versus Cetuximab plus Concurrent Chemoradiotherapy in Locally Ad-vanced Esophageal Squamous Cell Carcinoma Wang Jing1, Weiwei Yan1, Jinming Yu1, Hui Zhu1* 1Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, China

ABSTRACT_ID 95: Utilizing Organ-Sparing Marrow-Targeted Irradiation (OSMI) to Condition Patients with High-risk Hemato-logic Malignancies Prior to Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from a Pro-spective Pilot Study Meng Welliver Department of Radiation Oncology, Ohio State Univer-sity, USA Meeting will be adjourned at 1:00 PM but the room will be available until 4pm if anyone would like to make more extended meeting with any of the scientific oral or poster presenters.

Sunday, October 21, 2018, San Antonio, USA

1:15 PM - 2:45 PM

Room 007C/D, Henry B. Gonazalez Convention Center

Figure 1 Henry B. Gonazalez Convention Center

Big Data in Radiation Oncology (in Chinese): Challenges and Opportunities Co-Chairs: Zhongxing Liao, MD, FASTRO, MD Anderson Cancer Center Ken Zhen MD, FACR, FASTRO, University of Nebraska 1:15 PM - 1:30 PM Big Data Introduction (Definition, Source, etc.) Jinming Yu, MD, PhD, Shandong Cancer Hospital 1:30 PM - 1:45 PM CSTRO Strategy in Big Data Research to Guide Data Driven Decision Making

SANTRO Newsletter October 2018 Issue 2

8 | P a g e

Luhua Wang, MD, Radiation Oncology Services 1:45 PM - 2:00 PM How Big Data may Improve Clinical and Basic Research in Radiation Therapy? US Perspective Ying Xiao, PhD, DABR, University of Pennsylvania 2:00 PM - 2:15 PM Summary-Action Plan Jinyi Lang, MD, PhD, Sichuan Tumor Hospital 2:15 PM - 2:30 PM Case Presentation Min Yao, MD, PhD, University Hospitals Case Medical Center 2:30 PM - 2:45 PM Use Big Data to Better Define the Value of Radiation Therapy in China? Opportunities and Challenges (a case study) Ming Chen, MD, Zhejiang Tumor Hospital

6:00 PM - 10: 30 PM at Westin River Walk

Figure 2 Westin River Walk

SANTRO Dinner Reception at ASTRO 2018 Sponsored by Varian 6:00 PM - 7:00 PM Cocktail and Buffet Diner 7:00 pm - 7:30 pm 10-year SANTRO Celebration Activities Chair: Dian Wang, MD, Ying Li, MD, Brian Wang, PhD Greeting from the SANTRO President: Allen Li, PhD Welcome from the Sponsor: Kolleen Kennedy/Dow Wilson The 10 years’ Journey of SANTRO: Feng-Ming (Spring) Kong, MD Award Presentations: SANTRO Leaders 7:30 pm - 10:30 pm Dancing and Karaoke

SANTRO Newsletter October 2018 Issue 2

9 | P a g e

SANTRO at CSTRO 2018

Friday, November 9, 2018, Hangzhou, China

2:00 PM - 6:00 PM AT Room 308, Hangzhou Interna-tional Expo Center SANTRO Scientific Symposium Theme: The Latest Trends in Radiation Oncology Chair: Allen Li PhD, FAAPM, Medial College of Wiscon-sin Part I: Co-Chairs: Shiyu Song, MD, Virginia Commonwealth University Health System

Jing Jin (金晶), MD, Chinese National Cancer Insti-tute, Cancer Hospital 2:00 PM - 2:20 PM Technical Advances for Adaptive RT Allen Li, PhD, Medical College of Wisconsin 2:20 PM - 2:40 PM Adaptive RT for NSCLC Feng-Ming (Spring) Kong, MD, PhD 2:40 PM - 3:00 PM Technical Advances for SBRT FangFang Yin, PhD, Duke University Medical School 3:00 PM - 3:20 PM I-SBAR for Lung Cancer Joe Chang, MD, PhD 3:20 PM - 3:40 PM mpMRI-guided SBRT of Prostate Cancer Dian Wang, MD, Rush University 3.40 PM - 4:00 PM SBRT for Pancreatic Cancer Chi Lin, MD, University of Nebraska Medical Center

Part II Co-Chairs: Jeff Yue, PhD, Robert Wood Johnson University

Shuchai Zhu (祝淑钗), MD, The Fourth Hebei Medical

University Hospital 4:00 PM - 4:20 PM Management of Brain Tumors: Are We Making Pro-gress? Ken Zhen, MD, University of Nebraska 4:20 PM - 4:40 PM Chemoradiation with Immunotherapy in Head and Neck Cancer Min Yao, MD, Case Western Reserve University 4:40 PM - 5:00 PM Recent Developments in Radiation Therapy for Hema-tologic Malignancies Meng Welliver, MD, Ohio State University 5:00 PM - 5:20 PM Latest Trend in Palliative Radiation Therapy Ying Li, MD, University of Texas San Antonio 5:20 PM - 5:40 PM Data and Data-driven Clinical Decision Making in Ra-diation Oncology Lei Xing, PhD, Stanford University 5:40 PM - 6:00 PM New Skill Sets and Training for Modern Radiation On-cology Lei Dong, PhD, University of Pennsylvania

6:00 PM – Floor 5, Impression Restaurant, North Star Hangzhou International Expo Center Hotel SANTRO Reception Event Chair: Chi Lin, MD, PhD Co-sponsored by HGPT

SANTRO Newsletter October 2018 Issue 2

10 | P a g e

SANTRO Newsletter October 2018 Issue 2

11 | P a g e

SANTRO at Taizhou Symposium

December 8-10, 2018, Taizhou, China Taizhou Symposium Precision Medicine in Radiation Oncology, Win-win Opportunities in Collaborations between Physicians and Physicists, and in Conduct of Meaningful Clinical Trials

ACKNOLEDGEMENTS PLATINUM SPONSORS

This event is co-sponsored by

Together Bridging the Future

SANTRO Newsletter October 2018 Issue 2

12 | P a g e

SANTRO ORGANIZATION SANTRO Executive Committee

President: X. Allen Li, PhD Chair of Board: Weining Ken Zhen, MD President-Elect: Dian Wang, MD, PhD Secretary: Shiyu Song, MD, PhD Treasurer: Brian Wang, PhD Newsletter Editor: Chi Lin, MD, PhD

Past Presidents Feng-Ming (Spring) Kong, MD, PhD Fang-Fang Yin, PhD Joe Chang, MD, PhD Ning J. Yue, PhD Weining Ken Zhen, MD

Board of Directors

Joe Chang, MD, PhD Lei Dong, PhD Ying Hitchcock, MD Jian-Yue Jin, PhD Feng-Ming (Spring) Kong, MD, PhD Allen X Li, PhD Zhong-Xing Liao, MD Chi Lin, MD Bo Lu, MD Shiyu Song, MD, PhD Dian Wang, MD, PhD Ping Xia, PhD Ying Xiao, PhD Lei Xing, PhD Min Yao, MD Fang-Fang Yin, PhD Ning J. Yue, PhD Weining Ken Zhen, MD Ying Li, MD

Founding Board of Directors Yue Cao, PhD Joe Chang, MD, PhD Ying Hitchcock, MD Jian-Yue Jin, PhD Feng-Ming (Spring) Kong, MD, PhD Zhong-Xing Liao, MD Ping Xia, PhD Di Yan, PhD Fang-Fang Yin, PhD Ning J. Yue, PhD Weining Ken Zhen, MD.